This article describes how behavioral science can be applied in cardiometabolic clinical research to augment drug interventions. This combined approach addresses the Health Inequity gap while also increasing patient engagement.
It seems we can’t find what you’re looking for. Perhaps searching can help.
Insert HTML text here.